I’m sure this is an e-mail that the majority of the users on this forum received today, but if not I wanted to post it to make sure everyone continues doing their part. Please take the time to send emails and makes calls to the two FDA reps listed in the email. Thanks…
[b][Size=4]February 11, 2012
Dear PFS Patient,
The letter below was posted earlier this week by a member of the forum at PropeciaHelp (www.propeciahelp.com) who has written letters to many employees of the FDA.
It is time for collective action! It is time to make your voices heard! It is time to let the FDA know that you will not be ignored any longer! By overwhelming the FDA with the stories of large numbers of real patients, we can make a difference. Your direct communications with the FDA can make them understand on a real personal level how many lives have been dramatically altered by Propecia. Be persistent and be sure to follow up with the FDA multiple times, if possible. Get in their face, but be polite. Make sure they get the message. Let them know that this is a real problem that has affected real people.
Please write as many detailed letters and make as many phone calls as you can to Mary Ellen Taylor. Her contact information is listed below.
Please also send a copy of your letters and make as many phone calls as you can to Dr. Kavita Dada. Her contact information is as follows:
Kavita Dada
Senior Health Promotions Officer, Pharm. D.
Division of Drug Information
Center for Drug Evaluation and Research
Food and Drug Administration
10001 New Hampshire Avenue
Silver Spring MD 20993
(301) 796-3105
Dear Sir,
Thank you for contacting the Food and Drug Administration.
We are currently evaluating the potential safety signals of persistent sexual and neurocognitive adverse events associated with the use of Propecia. When our review is complete or significant data warrants, we will take regulatory actions as deemed necessary. If an action is taken, it will be reflected in the labeling of the product and/or a public advisory.
We understand your concerns and share your interest in protecting the populace from potentially adverse events while using medications.
Mary Ellen Taylor, MSPH
Public Affairs Specialist
FDA San Francisco District Office
1431 Harbor Bay Parkway
Alameda, CA 94502-7070
(510) 337-6888
(510) 337-6708 Fax
maryellen.taylor@fda.hhs.gov[/size][/b]